Report of the Working Group for Dietary Salt Reduction of the Japanese Society of Hypertension: (1) Rationale for Salt Restriction and Salt-Restriction Target Level for the Management of Hypertension


Salt excess is well known to be involved in the pathophysiology of hypertension, and thus restriction of salt intake is widely recommended for management of the disease. Excessive salt intake induces blood pressure (BP)−dependent as well as −independent progression of cardiovascular disease. Although the human body is considered to be adapted to very low salt intake (0.5–3 g/day), restriction to such a low level of salt intake is extremely difficult to accomplish in developed countries. Significant BP reduction has been reported in large-scale clinical studies in which salt intake was decreased to less than 6 g/day, and the results of a meta-analysis have shown that systolic BP was reduced about 1 mmHg with every decrease in salt intake of 1 g/day in hypertensive subjects. Current guidelines for the treatment of hypertension, including Japanese guidelines, recommend dietary salt reduction to 6 g/day or less in hypertensive patients. However, it appears to be fairly difficult to attain this target of salt intake, especially in Japan. There is thus a need for feasible and effective measures to attain this salt restriction target.


  1. 1

    Chobanian AV, Bakris GL, Black HR, et al: The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC-7 report. JAMA 2003; 289: 2560–2572.

  2. 2

    Guidelines Committee : 2003 European Society of Hypertension–European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011–1053.

  3. 3

    Japanese Society of Hypertension Guidelines Subcommittee for the Management of Hypertension : Guidelines for the Management of Hypertension for General Practitioners. Hypertens Res 2001; 24: 613–634.

  4. 4

    Japanese Society of Hypertension : Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2004). Hypertens Res 2006; 29 ( Suppl): S1–S105.

  5. 5

    Kawano Y, Ando K, Matsuura H, Tsuchihashi T, Fujita T, Ueshima H : Rationale of salt restriction and its target for the management of hypertension, in Report of the Working Group for Dietary Salt Reduction of the Japanese Society of Hypertension. Tokyo, Japanese Society of Hypertension, 2006, pp 1–12 ( in Japanese).

  6. 6

    Eaton SB, Eaton SB 3rd, Konner MJ, et al: An evolutionary perspective enhances understanding of human nutritional requirement. J Nutr 1996; 126: 1732–1740.

  7. 7

    Dahl LK : Salt intake and salt need. N Engl J Med 1958; 258: 1205–1208.

  8. 8

    Intersalt Cooperative Research Group: Intersalt: an international study of electrolyte excretion and blood pressure: results for 24 hour urinary sodium and potassium excretion. BMJ 1988; 297: 319–328.

  9. 9

    Lifestyle-Related Disease Control Section, General Affairs Division, Health Bureau, Ministry of Health, Labor and Welfare : An outline of the results of the 2004 National Health and Nutrition Survey (in Japanese).

  10. 10

    Kawano Y, Minami J, and Takishita S : Evaluation of the effects of mineral intake in hypertensive patients by blood pressure monitoring: combination of K, Ca, and Mg supplementation and Na restriction. Ther Res 1998; 19: 1517–1520 ( in Japanese).

  11. 11

    Ohta Y, Tsuchihashi T, Ueno M, et al: Relationship between the awareness of salt restriction and the actual salt intake in hypertensive patients. Hypertens Res 2004; 27: 243–246.

  12. 12

    Fujita T ( ed) : Salt and Hypertension. Tokyo, Nihon Igaku Shuppan, 2002 ( in Japanese).

  13. 13

    Stamler J, Rose G, Elliott P, et al: Findings of the international cooperative INTERSALT study. Hypertension 1991; 17 ( Suppl 1): I-9–I-15.

  14. 14

    Kawasaki T, Delea CS, Bartter FC, et al: The effect of high-sodium and low-sodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension. Am J Med 1978; 64: 193–198.

  15. 15

    Fujita T, Ando K, Ogata E : Systemic and regional hemodynamics in patients with salt-sensitive hypertension. Hypertension 1990; 16: 235–244.

  16. 16

    de Wardener HE, MacGregor GA : Harmful effects of dietary salt in addition to hypertension. J Hum Hypertens 2002; 16: 213–223.

  17. 17

    Tumilehto J, Jousilahti P, Rastenyte D, et al: Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet 2001; 357: 848–851.

  18. 18

    Nagata C, Takatsuka N, Shimizu N, et al: Salt intake and risk of death from stroke in Japanese men and women. Stroke 2004; 35: 1543–1547.

  19. 19

    He J, Ogden LG, Bazzano LA, et al: Dietary sodium intake and incidence of congestive heart failure in overweight US men and women: First National Health and Nutrition Examination Survey Epidemic Follow-up study. Arch Intern Med 2002; 162: 1619–1624.

  20. 20

    Ito K, Kuroda K, Tsuchiya M, et al: Gradient salt reduction and its antihypertensive effect in patients with essential hypertension. Magnesium 1982; 1: 224–231.

  21. 21

    The Trials of Hypertension Prevention Collaborative Research Group: The effects of nonpharmacologic interventions on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. JAMA 1992; 267: 1213–1220.

  22. 22

    Whelton PK, Appel AJ, Espeland MA, et al: Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA 1998; 279: 839–846.

  23. 23

    He J, Whelton PK, Appel LJ, et al: Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. Hypertension 2000; 35: 544–549.

  24. 24

    Sacks FM, Svetkey LP, Vollmer WM, et al: Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med 2001; 344: 3–10.

  25. 25

    The Trials of Hypertension Prevention Collaborative Research Group: Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure: the Trials of Hypertension Prevention, phase II. Arch Intern Med 1997; 157: 657–667.

  26. 26

    Hypertension Prevention Trial Research Group: The Hypertension Prevention Trial: three-year effects of dietary changes on blood pressure. Arch Intern Med 1990; 150: 153–162.

  27. 27

    He FJ, MacGregor GA : Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens 2002; 16: 761–770.

  28. 28

    Oshima T, Matsuura H, Kido K, et al: Factors determining sodium chloride sensitivity of patients with essential hypertension: evaluation by multivariate analysis. J Hypertens 1989; 7: 223–227.

  29. 29

    Kawano Y, Abe H, Kojima S, et al: Different effects of alcohol and salt on 24-hour blood pressure and heart rate in hypertensive patients. Hypertens Res 1996; 19: 255–261.

  30. 30

    Ando K, Takahashi K, Shimosawa T, et al: Effect of aging on salt sensitivity of blood pressure in patients with essential hypertension. Clin Exp Nephrol 1999; 1: 18–22.

  31. 31

    Uzu T, Ishikawa K, Fujii K, et al: Sodium restriction shifts circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation 1997; 96: 1859–1862.

  32. 32

    Luft FC, Miller JZ, Grimm CE, et al: Salt sensitivity and resistance of blood pressure: age and race as factors in physiological responses. Hypertension 1991; 17: I-102–I-108.

  33. 33

    Adrogue HJ, Madias NE : Sodium and potassium in the pathogenesis of hypertension. N Engl J Med 2007; 356: 1966–1978.

  34. 34

    Cook NR, Cutler JA, Obarzanek E, et al: Long term effects of dietary sodium restriction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ 2007; 334: 885–888.

  35. 35

    Kawano Y, Omae T : Lifestyle modifications in the management of hypertension: effects and limitations. CVD Prevention 1998; 1: 336–346.

  36. 36

    Espeland MA, Whelton PK, Kostis JB, et al: Predictors and mediators of successful long-term withdrawal from antihypertensive medications. TONE Collaborative Research Group. Trial of Nonpharmacologic Intervention in the Elderly. Arch Fam Med 1999; 8: 228–236.

  37. 37

    Tsunematsu N, Ueshima H, Okuda N, et al: The actual amount of reductions in salt intake among those on a restricted salt diet: from the INTERMAP Japan. J Jpn Soc Prev Cardiovasc Dis 2004; 39: 149–155.

  38. 38

    Neaton JD, Grimm RH Jr, Prineas RJ, et al: Treatment of Mild Hypertension Study: final results. JAMA 1993; 270: 713–724.

  39. 39

    Hooper L, Bartlett C, Smith GD, et al: Systematic review of long term effects of advice to reduce dietary salt in adults. BMJ 2002; 325: 628–632.

Download references

Author information

Correspondence to Yuhei Kawano.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kawano, Y., Ando, K., Matsuura, H. et al. Report of the Working Group for Dietary Salt Reduction of the Japanese Society of Hypertension: (1) Rationale for Salt Restriction and Salt-Restriction Target Level for the Management of Hypertension. Hypertens Res 30, 879–886 (2007).

Download citation


  • dietary salt
  • hypertension
  • cardiovascular disease
  • guidelines
  • large-scale clinical study

Further reading